EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2

Junyi Wei, Quanyou Chai, Yuqiao Qin, Long Li, Chunling Guo, Zhaoyang Lu, Huimin Liu

Molecular Medicine · 21.11.2024 · 30 (1)

DOI: 10.1186/s10020-024-01002-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine, online erschienen am 21.11.2024. Verfasst von Junyi Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Ferroptosis, Quercetin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperoside (quercetin-3-O-β-D-galactopyranoside) is a flavonol glycoside compound derived from plants in the Hypericum and Crataegus genera that reportedly exhibits an array of anti-inflammatory, antioxidant, and antitumor properties such that it has been used to treat various diseases. Whether it can serve as an effective treatment for chronic myeloid leukemia (CML) cells, however, has yet to be established. The present study was thus devised to assess the therapeutic effects of hyperoside on CML cells and to clarify the underlying mechanism of action.

Methods

Cellular viability, proliferative activity, migration, and apoptotic death were respectively analyzed through CCK-8, EDU, transwell, and flow cytometry assays. RNA-seq and bioinformatics approaches were further employed to evaluate the mechanisms through which hyperoside influences CML cells, while analyses of reactive oxygen species (ROS) and free iron were detected with commercial kits. Transmission electron microscopy was used to assess mitochondrial morphology. Molecular docking, cellular thermal shift assay (CETSA), and drug affinity responsive target stability (DARTS) approaches were also used to explore the ability of hyperoside to target NRF2.

Results

From a mechanistic perspective, hyperoside was able to inhibit SLC7A11/GPX4 signaling in a manner that was abrogated by the ferroptosis inhibitor ferrostatin-1. NRF2 was also closely associated with the inactivation of the SLC7A11/GPX4 axis mediated by hyperoside such that overexpressing NRF2 ablated the benefits associated with hyperoside treatment.

Conclusions

The present analyses indicate that hyperoside can target the NRF2/SLC7A11/GPX4 axis to induce ferroptotic CML cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Leukemia, Myelogenous, Chronic, BCR-ABL PositiveFerroptosisQuercetinMolecular Docking SimulationHumansCell Line, TumorReactive Oxygen SpeciesCell ProliferationCell SurvivalApoptosisSignal Transduction

Stichwörter der Autor:innen

Chronic myeloid leukemiaFerroptosisHyperosideNRF2

Substanzen

NF-E2-Related Factor 2QuercetinhyperosideNFE2L2 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Immunology, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, China.
  • Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China.
  • Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Department of Cardiology, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, and Engineering Research Center for Cardiovascular Innovative Devices of Zhejiang Province, Hangzhou, China.
  • Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, China.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Wei, J., Chai, Q., Qin, Y., Li, L., Guo, C., Lu, Z., & Liu, H. (2024). Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2. Molecular Medicine, 30(1). https://doi.org/10.1186/s10020-024-01002-7

Vancouver

Wei J, Chai Q, Qin Y, Li L, Guo C, Lu Z, et al. Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2. Molecular Medicine. 2024;30(1). doi:10.1186/s10020-024-01002-7

BibTeX
@article{Wei2024,
  author = {Wei, Junyi and Chai, Quanyou and Qin, Yuqiao and Li, Long and Guo, Chunling and Lu, Zhaoyang and Liu, Huimin},
  title = {Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2},
  journal = {Molecular Medicine},
  year = {2024},
  volume = {30},
  number = {1},
  doi = {10.1186/s10020-024-01002-7}
}
Kostenlos starten →